EUVIMED · CrossrefZeitschrift
Journal of Immune Based Therapies and Vaccines
ISSN 1476-8518 · Springer Science and Business Media LLC
Neueste Artikel
HIV-1 sub-type C chimaeric VLPs boost cellular immune responses in mice
Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up
Tumor–associated antigens identified by mRNA expression profiling as tumor rejection epitopes
Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model
A Canadian national survey of attitudes and knowledge regarding preventive vaccines
Welcome to the Journal of Immune Based Therapies and Vaccines (JIBTV)
Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gagpeptides in liposomes and ISCOMs with in-built adjuvanticity
Dendritic cells: In the forefront of immunopathogenesis and vaccine development – A review
Development of a model of focal pneumococcal pneumonia in young rats
The effects of chemotherapeutics on cellular metabolism and consequent immune recognition
Current problems of perinatal Chlamydia trachomatisinfections
Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed
Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control study
Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor
Identification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD)
Antigenized antibodies expressing Vβ8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis
BCG vaccination at three different age groups: response and effectiveness
Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant
Granulocyte-macrophage colony-stimulating factor as an immune-based therapy in HIV infection
Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading
The significance of glucose, insulin and potassium for immunology and oncology: a new model of immunity
Psoriatic arthritis: Pathogenesis and novel immunomodulatory approaches to treatment
Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: Beneficial effect of IL-2 and GM-CSF immunotherapy
Cellular metabolism as a basis for immune privilege
A novel method to identify and characterise peptide mimotopes of heat shock protein 70-associated antigens
Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patients
Modulation of humoral immune response to oral BCG vaccination by Mycobacterium bovis BCGMoreau Rio de Janeiro (RDJ) in healthy adults
Phytol-based novel adjuvants in vaccine formulation: 2. assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice
Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses
EUVIMED